(Q47906737)

English

Assessment of HER‐2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?

scientific article published on March 1, 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice? (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

Assessment of HER‐2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice? (English)

1 reference

10.1034/J.1600-0463.2003.T01-1-1110210.X

https://api.crossref.org/works/10.1034/J.1600-0463.2003.T01-1-1110210.X

3 January 2024

5

object named as

Rolf Karesen

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

author name string

Torill Sauer

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

Gro Wiedswang

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

Ghania Boudjema

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

Hanne Christensen

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

Rolf Karesen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752225

3 January 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12752225

3 January 2024

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0463.2003.t01-1-1110210.x

1 reference

10.1034/J.1600-0463.2003.T01-1-1110210.X

https://api.crossref.org/works/10.1034/J.1600-0463.2003.T01-1-1110210.X

3 January 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1600-0463.2003.t01-1-1110210.x

1 reference

10.1034/J.1600-0463.2003.T01-1-1110210.X

https://api.crossref.org/works/10.1034/J.1600-0463.2003.T01-1-1110210.X

3 January 2024

Acta Pathologica et Microbiologica Scandinavica

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

111

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

444-450

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

21 January 2018

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

21 January 2018

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

21 January 2018

HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

21 January 2018

Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

21 January 2018

Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

21 January 2018

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

21 January 2018

Immunohistochemical determination of HER-2/neu expression in invasive breast carcinoma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

21 January 2018

Assessment of HER-2/neu Status in Breast Cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110210.X

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB2 oncogene in human breast cancer and its clinical significance

8

1 reference

10.1034/J.1600-0463.2003.T01-1-1110210.X

https://api.crossref.org/works/10.1034/J.1600-0463.2003.T01-1-1110210.X

3 January 2024

Ploidy analysis by in situ hybridization of interphase cell nuclei in fine-needle aspirates from breast carcinomas: correlation with cytologic grading

25

1 reference

10.1034/J.1600-0463.2003.T01-1-1110210.X

https://api.crossref.org/works/10.1034/J.1600-0463.2003.T01-1-1110210.X

3 January 2024

Identifiers

10.1034/J.1600-0463.2003.T01-1-1110210.X

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12752225

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47906737&oldid=2121586333"